Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Biolitec Pharma
Biolitec Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Foscan
Temoporfin
2001-10-24
Head and neck neoplasms
,
Squamous cell neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
TEMOPORFIN
squamous cell carcinoma
,
carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
bile duct neoplasms
,
ductal carcinoma
,
recurrence
,
oropharyngeal neoplasms
,
tongue neoplasms
,
verrucous carcinoma
Pdt
actinic keratosis
,
keratosis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use